(PharmaNewsWire.Com, April 22, 2024 ) As per Maximize Market research, the Liver Disease Therapeutics Market was USD 21.10 Billion in 2023 and is expected to grow at a CAGR of 7.4 percent over the forecast period to reach USD 34.78 Billion by 2030.
Liver Disease Therapeutics Market Report Scope and Research Methodology
A research methodology involves reliable data sources, primary interviews, and statistical analysis, the report ensures accuracy and reliability. It delivers valuable insights for stakeholders seeking a nuanced understanding of the Liver Disease therapeutics market, aiding informed decision-making. The Liver Disease Therapeutics Market Report broadly examines the landscape of liver disease therapeutics, encompassing market trends, competitive analysis, and growth influencers.
Chronic liver diseases are estimated to affect more than 800 million people around the world. Rising public drinking is the main factors that bring about more and more people with alcohol problems. The major causes of hepatitis-related deaths are chronic viral infections with hepatitis B (HBV) and hepatitis C (HCV) along with alcohol-related liver disease and non-alcoholic fatty liver disease.
North America with the largest share in the Global Liver Disease Therapeutics Market; in 2023. It is expected to have a CAGR of 7.4% over the forecast period. The lifestyle that residents in this region are accustomed to things such as alcohol drinking and unhealthy eating habits has correlated with a significant rise in liver diseases in the area.
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
